Recent Publications
1. Gupta PK, Orlovskiy S, Arias-Mendoza F, Nelson DS, Nath K. 1H and 31P Magnetic Resonance Spectroscopic Metabolomic Imaging: Assessing Mitogen-Activated Protein Kinase Inhibition in Melanoma. Cells. 2024 Jul 19;13(14):1220. doi: 10.3390/cells13141220. PMID: 39056801; PMCID: PMC11274771.
2. Nath K, Gupta PK, Basappa J, Wang S, Sen N, Lobello C, Tomar JS, Shestov AA, Orlovskiy S, Arias-Mendoza F, Rauert-Wunderlich H, Nelson DS, Glickson JD, Wasik MA. Impact of therapeutic inhibition of oncogenic cell signaling tyrosine kinase on cell metabolism: in vivo-detectable metabolic biomarkers of inhibition. J Transl Med. 2024 Jul 4;22(1):622. doi: 10.1186/s12967-024-05371-9. PMID: 38965536; PMCID: PMC11225145.
3. Orlovskiy S, Gupta PK, Roman J, Arias-Mendoza F, Nelson DS, Koch CJ, Narayan V, Putt ME, Nath K. Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy. Cancers (Basel). 2024 Mar 31;16(7):1384. doi: 10.3390/cancers16071384. PMID: 38611062; PMCID: PMC11010960.
4. Gupta PK, Orlovskiy S, Arias-Mendoza F, Nelson DS, Osborne A, Pickup S, Glickson JD, Nath K. Metabolic Imaging Biomarkers of Response to Signaling Inhibition Therapy in Melanoma. Cancers (Basel). 2024 Jan 15;16(2):365. doi: 10.3390/cancers16020365. PMID: 38254853; PMCID: PMC10814512
5. Gupta PK, Orlovskiy S, Roman J, Pickup S, Nelson DS, Glickson JD, Nath K. pH-dependent structural characteristics of lonidamine: 1H and 13C NMR study. RSC Adv. 2023 Jul 3;13(29):19813-19816. doi: 10.1039/d3ra01615c. PMID: 37404315; PMCID: PMC10316351.
Contact Us
Email:
Kavindra.Nath@pennmedicine.upenn.edu
Phone: 215-746-7386
Fax: 215-573-2113